A Strategy for the In-Silico Assessment of Drug Eluting Stents: A Comparative Study for the Evaluation of Retinoic Acid as a Novel Drug Candidate for Drug Eluting Stents.

In this work, a methodology for the in-silico evaluation of drug eluting stents (DES) is presented. A stent model developed by Rontis S.A.

Advancing In Silico Clinical Trials for Regulatory Adoption and Innovation.

The evolution of information and communication technologies has affected all fields of science, including health sciences. However, the rate of technological innovation adoption by the healthcare sector has been historically slow, compared to other industrial sectors. Innovation in computer modeling and simulation approaches has changed the landscape in biomedical applications and biomedicine, paving the way for their potential contribution in reducing, refining, and partially replacing animal and human clinical trials.

Mechanical Barrier for Prevention of Dislodged Stent Embolization in Saphenous Vein Graft.

Percutaneous coronary interventions in vein grafts can be quite challenging, and many complications can occur during the procedure. We present a case of stent dislodgment during percutaneous coronary intervention in a vein graft. It was migrating to the proximal part of the graft and a covered stent was placed in the native vessel in order to isolate the graft.